Magnetic Resonance Imaging of Brain Development in Autism
NCT ID: NCT00449566
Last Updated: 2007-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI Brain (Volumetry, fMRI & MRS) in Autism
NCT05758220
MRI Study of Cerebral Blood Flow in Development Disorders in Children
NCT02165410
Brain Imaging in Children With AD/HD
NCT00008892
MRI Study of Subjects with ASD, Their Relatives and TD
NCT05470088
Developing Advanced MRI Methods for Detecting the Impact of Nutrients on Infant Brain Development
NCT02058225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1\) DSM-IV (APA, 1994) diagnosis of autism, according to ADI-R interview
1. no DSM-IV (APA, 1994) diagnosis, according to DISC interview
2. no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)
3. IQ \> 70
Exclusion Criteria
2. presence of metal objects in or around the body (pacemaker, dental braces)
3. history of or present neurological disorder
4. for individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based
6 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMC Utrecht
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Durston, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht
Herman van Engeland, M.D. Ph.D.
Role: STUDY_CHAIR
Rudolf Magnust Institute of Neuroscience, UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Child and Adolescent Psychiatry, UMC Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Langen M, Durston S, Staal WG, Palmen SJ, van Engeland H. Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry. 2007 Aug 1;62(3):262-6. doi: 10.1016/j.biopsych.2006.09.040. Epub 2007 Jan 16.
Related Links
Access external resources that provide additional context or updates about the study.
Lab homepage with info for subjects (in Dutch)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC 05/208-K
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.